The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

401 CONGRESS AVENUE, SUITE 2500, AUSTIN,TEXAS 78701-3799, USA
Tel:
Work +1 512 457 7000
Fax:
Fax +1 512 457 7001
Email:
Web:
www.dlapiper.com

Aaron Fountain

Tel:
Work 1 512 457 7190
Email:
DLA Piper LLP (US)

Work Department

Intellectutal Property

Position

Partner

Career

Aaron Fountain concentrates his practice on patent litigation and other intellectual property related matters. Aaron has extensive experience representing clients in dozens of patent infringement matters in the Eastern District of Texas and the District of Delaware. Aaron has also represented clients before the USPTO, including inter partes review proceedings before the Patent Trial and Appeal Board and providing strategic patent portfolio management advice. His clients span a range of technologies, including molecular diagnostics, topical pharmaceuticals, telecom infrastructure, set top boxes, oil field services and all manner of software.

Education

JD, University of Houston Law Center; BS, Pepperdine University


United States: Industry focus

Healthcare: life sciences

Within: Next generation lawyers

Aaron Fountain - DLA Piper LLP (US)

Within: Healthcare: life sciences

DLA Piper LLP (US)’s ‘excellent, responsive and knowledgeable’ department has considerable experience assisting high-profile clients with regulatory, transactional and IP matters, as well as complex global disputes. San Diego-based co-head Lisa Haile and New York-based Stuart Pollack have been leading advice to SteadyMed on various patent invalidation claims brought against United Therapeutics before the Patent Trial and Appeal Board (PTAB). Co-head Richard Mulloy and Drew Wintringham, who are in San Diego and New York, respectively, have been representing Covidien in patent litigation brought against Ethicon arising from the release of Ethicon’s Enseal X1 medical device. The team also acted for Sanpower Group on its $820m acquisition of Dendreon Pharmaceuticals. Also led by product liability expert Matthew Holian in Boston, the team includes George Karavetsos in Miami, Loren Brown in New York, Raymond Williams in Philadelphia, Larry Nishnick in San Diego and Aaron Fountain, who splits his time between Austin and Houston.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to